Medical use
AssigneeSmithKline Beecham Corporation
InventorsCharanjit Bountra, Malcolm Stuart Nobbs
Life of this patent
Estimating the term…
Abstract
The present invention relates to the use of sodium channel antagonists in the treatment of diseases mediated by, or exacerbated by, neuronal apoptosis, in particular sensory neuronal apoptosis.
Claims15
A method for the treatment of a mammal, suffering from or susceptible to diseases mediated by, or exacerbated by, neuronal apoptosis, comprising administration of an effective amount of a sodium channel antagonist.
A method for delaying or halting the progression of diseases selected from pain states following nerve insult, neurodegenerative diseases and inflammation in a mammal, comprising administration of an effective amount of a sodium channel antagonist.
Dependencies are inferred from the claim text.